EMERYVILLE, Calif., Oct. 22, 2025 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company developing and commercializing innovative vaccines, will report third quarter 2025 financial results on Wednesday, November 5, 2025, after the...
Dynavax to Report Third Quarter 2025 Financial Results and Host Conference Call on November 5, 2025
Seeking Alpha / 10 hours ago 1 Views
Comments